Over 70 emerging growth biotech, medtech, healthcare IT, and healthcare services companies have been confirmed to present at the quickly approaching summer finance OneMedForum, being held in New York City on June 29th and 30th.
RepRegen, formerly known as BioCeramic Therapeutics, is developing a repair and regeneration technology platform designed to mend and repair hard tissue such as bone and soft tissue such as cartilage.
Ischemic stroke, or a stroke that occurs in the brain, is an acutely time-sensitive disease: The longer it goes untreated, the more likely death or severe brain damage will result. Unfortunately, the current standard for treating ischemic stroke is time-sensitive as well.
One type of nanoparticle currently in development engages in “active targeting,” or targeting drugs to cancer cells by attaching them to a molecule that the cancer cell is receptive to.
The company is a medical devices company that has developed an apparatus for advanced diagnostic analysis of cervical tissue, which serves as a routine screening […]
The company is a medical device company that had developed an apparatus for determining an individuals risk for thrombosis, or adverse blood clot formation can […]
The company is a medical devices company that has used its proprietary technology to develop leading-edge automated medical diagnostic products for the detection of healthcare […]
The company is a medical devices company that has developed a technology for facilitating the connection of blood vessels in bypass graft surgeries. The company’s […]
The company is a medical devices company that has developed a novel therapeutic approach for ablation of solid tumors in cancer patients. The technology uses […]
Copyright © 2024 | WordPress Theme by MH Themes